Fig. 1From: Sarcopenia as a prognostic factor in patients with recurrent pancreatic cancer: a retrospective studyTwo-year post-recurrence overall survival curves in recurrent pancreatic cancer patients. Patients with low PMI (sarcopenia group) and with normal PMI (non-sarcopenia group) are compared. PMI, psoas muscle index; MST, median survival timeBack to article page